Sonic Healthcare: Interim result 2014

A robust result for Sonic as Australian pathology grows strongly.

Sonic Healthcare announced a solid half-year result with revenue increasing 12% to $1.9bn compared to the prior corresponding period. Earnings before interest, tax, depreciation and amortisation (EBITDA) was 13% higher at $344m, while net profit was up a very healthy 18% to $177m, mainly due to favourable exchange rate movements and lower interest costs. Earnings per share increased 16% to 44 cents and an interim dividend of 27 cents was declared (45% franked, ex date 6 March), an increase of 8%, for a current yield of 3.8%.


{{ twilioFailed ? 'SMS Code Failed to Send…' : 'SMS Code Sent…' }}

Hi {{ user.FirstName }}

Looks like you've already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number to unlock a FREE trial

Please sign up for full access

Updating information

Please wait ...

  • Mastercard
  • Visa

The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device

Register as a new member

(using a different email)

Related Articles